Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gender's role in BPD: a new study seeks answers

NCT ID NCT07639957

Knowledge-focused Sponsor: University Hospital Heidelberg Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at how gender affects the way people with borderline personality disorder (BPD) see themselves and their relationships. Researchers will interview 15 people with BPD of different gender identities and use special tests to measure hidden thoughts. The goal is to better understand these experiences, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The majority of recruitment takes place among participants in the study "Mentalization-based treatment versus bona-fide treatment for patients with Borderline Personality Disorder in Germany (MAGNET): a prospective, multi-center randomized controlled trial" (S-493/2023). Only those participants who indicated in the MAGNET study consent form that they consent to being contacted for further studies and have not withdrawn this consent will be contacted. In addition, individuals with diverse gender identities may be recruited through the Institute for Psychosocial Prevention and Psychotherapy at Heidelberg University Hospital using flyers (posted at the institute, on the website, and distributed during initial consultations)

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Signed informed consent form 2. Individuals of all genders (target: n=5 with female gender identity, n=5 with nonbinary/trans\*/gender-non-conforming (TGNC) gender identity, n=5 with male gender identity) between the ages of 18 and 65 at the time of consent 3. Individuals with a BPD diagnosis made within the last 2 years (ICD-10: F60.3; DSM-5: 301.83, ICD-11: Borderline qualifier) 4. Understanding of the study procedure, ability and willingness to participate 5. The participant is able to read and understand the informed consent form and can provide a written, personally signed, and dated informed consent form. Exclusion Criteria: 1. Acute suicidal ideation or acute psychotic symptoms reported by the patient or suspected 2. Insufficient language skills (i.e., knowledge of German or English)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Borderline personality disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

borderline personality disorder Coitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Borderline personality disorder (BPD)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institute for Psychosocial Prevention and Psychotherapy, University Hospital Heidelberg

    RECRUITING

    Heidelberg, 69115, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.